We have spent the last three years helping clinics and telehealth providers navigate Google's health advertising policies for GLP-1 medications. The enforcement landscape shifted dramatically in early 2025 when Google began automatically rejecting any ad that mentions semaglutide, tirzepatide, or compounded versions without verified certification. Here is what we have learned about getting those approvals through.
Why Google Rejects GLP-1 Ads
Google classifies GLP-1 medications as prescription pharmaceuticals. Under Google's Healthcare and Medicines policy, advertisers must complete a certification process that includes verification of pharmacy licenses, prescriber credentials, and compliance with the FDA's prescription drug advertising requirements under 21 CFR Part 202. Without this certification, any ad mentioning a GLP-1 compound by name gets an automatic rejection within minutes.
The problem gets worse for compounding pharmacies and telehealth clinics offering compounded semaglutide or tirzepatide. Google does not distinguish between FDA-approved brand-name versions (Ozempic, Wegovy, Mounjaro, Zepbound) and compounded versions produced under FDA 503A or 503B regulations. The automated system sees the drug name and blocks the ad regardless of your compounding license status.
The Certification Process Step by Step
Get your pharmacy credentials verified. Google requires a valid NPI number, state pharmacy board license, and proof of compliance with the DSCSA (Drug Supply Chain Security Act). For compounding pharmacies, this means having your FDA registration under Section 503B of the FDCA, or proof of state-level 503A compliance. We submitted our first certification package in January 2025 and received approval in three weeks.
Submit a prescription verification plan. Google wants to see documentation that you are not selling prescription medications without a valid prescription. This means showing your telemedicine workflow: how patients are screened, how prescriptions are issued by licensed providers, and how medications are dispensed. Under the Ryan Haight Online Pharmacy Consumer Protection Act, at least one in-person or real-time telemedicine consultation is required before prescribing controlled substances. GLP-1s are not scheduled, but Google applies the same scrutiny.
Get your website reviewed. Google will manually review your landing page for claims about weight loss results, before-and-after imagery, and specific outcome promises. The FTC's 2022 guidelines on endorsements and testimonials in the weight loss industry apply here. Any claim like: "Lose 15 pounds in one month" or "Clinically proven results" will trigger a rejection, even if your certification is approved.
How We Got a Telehealth Clinic Approved
One of our clients, a Texas-based telehealth clinic offering compounded semaglutide, had their ads rejected seven times over four months. The root cause was not their pharmacy license, which was valid, but their landing page. They had a section titled "12-Week Transformation Results" with patient photos that Google flagged as deceptive. We replaced it with a clinical FAQ citing the STEP clinical trials (Semaglutide Treatment Effect in People with Obesity) and removed all individual result claims. The ad was approved within 48 hours of the resubmission. The clinic now runs GLP-1 ads profitably at a 4.2x ROAS.
The key takeaway: Google's certification is the gate, but your landing page is the lock. You can have every license in place and still get rejected if your page makes claims that look like a weight loss scam.
Compounding Pharmacy GLP-1 Ads
FDA 503A compounding pharmacies must prove they are compounding from bulk drug substances that appear on the FDA's clinical need list. As of 2025, semaglutide and tirzepatide are not on this list, which means compounding pharmacies operating under 503A face additional scrutiny. We have had success getting approvals by framing the ad around the clinic's services rather than the specific drug. Ad copy that reads: "Medical weight loss consultations available" performs better than "Compounded semaglutide for weight loss" because it avoids the prescription drug trigger words.
FDA 503B outsourcing facilities have a stronger position because they operate under FDA-registered CGMP (Current Good Manufacturing Practice) standards. If you are a 503B facility, include your FDA establishment registration number in your certification submission. This gives Google's review team a clear reference to verify your compliance.
The DSHEA 1994 framework does not directly apply to GLP-1 products, which are prescription drugs, not dietary supplements. However, some clinics market GLP-1s alongside nutraceutical supplements for weight loss support. If your ad mentions both, Google requires separate certifications for the prescription drug component and the supplement component.
Common Rejection Reasons and Fixes
Unapproved pharmaceuticals. This usually means Google cannot verify your pharmacy credentials. Check that your NPI is active and your pharmacy board license is current. We had one client whose NPI was registered to an old address, causing a mismatch with Google's verification database.
Misleading or exaggerated claims. Remove all specific weight loss numbers, timeframes, and before-and-after images. Replace with general language: "May support weight management goals under medical supervision."
Inadequate prescriber oversight. Google wants to see that a licensed medical professional is involved in the prescribing process. If your model uses a questionnaire-only approach without a live consultation, you will not pass certification. Implement a video consultation workflow and document it in your submission.
What Changes We Expect in 2026
Google announced expanded health advertising requirements effective Q2 2026 that will require additional documentation for all prescription drug advertisers. The new policy includes mandatory third-party verification of compounding pharmacy licenses through LegitScript or NABP. We recommend getting your LegitScript verification in progress now before the deadline hits.
Download our compliance checklist to make sure your certification package covers everything Google requires. We have seen too many clinics waste months on rejections that could have been avoided with proper preparation.
Ready to get your GLP-1 ads running on Google? Book a call at calendly.com/custodio-2/30min and we will audit your current setup in 30 minutes.